Advances in systemic therapy for metastatic breast cancer: future perspectives
2017 · Medical Oncology · 43 citations
https://doi.org/10.1007/s12032-017-0975-5
G
Giandomenico Roviello
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
432
Papers
7.8K
Citations
43
h-index
174
i10-index
Giandomenico Roviello is an academic researcher from University of Florence. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Renal cell carcinoma treatment & Prostate Cancer Treatment and Research. The author has an h-index of 43, co-authored 368 publications.
ORCID: 0000-0001-5504-8237Papers by this author
worksAdvances in anti-BRAF therapies for lung cancer
2021 · Investigational New Drugs · 39 citations
https://doi.org/10.1007/s10637-021-01068-8
Immunotherapy-related biomarkers: Confirmations and uncertainties
2023 · Critical Reviews in Oncology/Hematology · 36 citations
https://doi.org/10.1016/j.critrevonc.2023.104135
Addition of androgen receptor-targeted agents to androgen-deprivation therapy and docetaxel in metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis
2022 · ESMO Open · 31 citations
https://doi.org/10.1016/j.esmoop.2022.100575
Current status and future perspectives in HER2 positive advanced gastric cancer
2022 · Clinical & Translational Oncology · 26 citations
https://doi.org/10.1007/s12094-021-02760-0
Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand?
2021 · Gastric Cancer · 25 citations
https://doi.org/10.1007/s10120-021-01182-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat